Viewing Study NCT03905135


Ignite Creation Date: 2025-12-24 @ 10:43 PM
Ignite Modification Date: 2026-01-02 @ 11:26 PM
Study NCT ID: NCT03905135
Status: COMPLETED
Last Update Posted: 2022-09-13
First Post: 2019-04-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies
Sponsor: National Cancer Institute (NCI)
Organization: